VEGFA and diabetes mellitus: In addition to managing and treating modifiable risk factors in patients with diabetes mellitus, the standard treatment for proliferative DR and/or diabetic macular oedema typically includes laser photocoagulation and/or intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents.